Eva Frei
Impact in
- Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism
- Toxicology top 0.1%
- Bioactive Compounds and Antitumor Agents
Papers in
- Pharmacology 92
- Pharmacogenetics and Drug Metabolism 92
- Toxicology 50
- Bioactive Compounds and Antitumor Agents 50
- Co-authors
- Marie Stiborová (153 shared papers)Heinz H. Schmeiser (82 shared papers)Manfred Wießler (42 shared papers)Volker Manfred Arlt (47 shared papers)Petr Hodek (33 shared papers)Václav Martínek (24 shared papers)Jitka Poljaková (17 shared papers)David H. Phillips (17 shared papers)
- Journals
- Chemical Research in Toxicology (11 papers)Cancer Letters (11 papers)Carcinogenesis (11 papers)Biochemical Pharmacology (8 papers)Toxicology (7 papers)
- Partner nations
- GermanyCzechiaUnited Kingdom
In The Last Decade
Eva Frei
219 papers receiving 5.8k citations
Peers
Comparison fields: 5 of 119
- Pharmacology 1.4k
- Toxicology 568
- Cancer Research 1.1k
- Radiology, Nuclear Medicine and Imaging 1.1k
- Biomaterials 337
Countries citing papers authored by Eva Frei
This map shows the geographic impact of Eva Frei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Frei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Frei more than expected).
Fields of papers citing papers by Eva Frei
This network shows the impact of papers produced by Eva Frei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Frei. The network helps show where Eva Frei may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Frei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 222 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sudan I is a potential carcinogen for humans: evidence for its metabolic activation and detoxication by human recombinant cytochrome P450 1A1 and liver microsomes. | 2002 | 269 |
| 2 | 2001 | 141 | |
| 3 | 2011 | 137 | |
| 4 | 2010 | 132 | |
| 5 | 2007 | 125 | |
| 6 | 2004 | 120 | |
| 7 | 2005 | 112 | |
| 8 | 2001 | 110 | |
| 9 | 2007 | 107 | |
| 10 | 2004 | 90 | |
| 11 | 2011 | 90 | |
| 12 | 1994 | 88 | |
| 13 | Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society. | 1999 | 84 |
| 14 | 2007 | 77 | |
| 15 | 2015 | 75 | |
| 16 | 2002 | 74 | |
| 17 | 2011 | 74 | |
| 18 | 2016 | 74 | |
| 19 | 2003 | 72 | |
| 20 | 2002 | 69 |
About Eva Frei
Eva Frei is a scholar working on Pharmacology, Toxicology, Cancer Research, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 222 papers that have together received 6k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (92 papers), Carcinogens and Genotoxicity Assessment (67 papers), Bioactive Compounds and Antitumor Agents (50 papers), Nephrotoxicity and Medicinal Plants (30 papers), Cancer therapeutics and mechanisms (18 papers), Synthesis and bioactivity of alkaloids (14 papers), Protein Interaction Studies and Fluorescence Analysis (10 papers) and Nanoparticle-Based Drug Delivery (8 papers). The work is most often cited by research in Pharmacology (1.4k citations), Toxicology (568 citations), Cancer Research (1.1k citations), Radiology, Nuclear Medicine and Imaging (1.1k citations) and Biomaterials (337 citations). Eva Frei has collaborated with scholars based in Germany, Czechia and United Kingdom. Frequent co-authors include Marie Stiborová, Heinz H. Schmeiser, Manfred Wießler, Volker Manfred Arlt, Petr Hodek, Václav Martínek, Jitka Poljaková, David H. Phillips, René Kizek and Christian A. Bieler. Their work appears in journals such as Chemical Research in Toxicology, Cancer Letters, Carcinogenesis, Biochemical Pharmacology and Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.